1. Home
  2. PRGO vs FOLD Comparison

PRGO vs FOLD Comparison

Compare PRGO & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRGO
  • FOLD
  • Stock Information
  • Founded
  • PRGO 1887
  • FOLD 2002
  • Country
  • PRGO Ireland
  • FOLD United States
  • Employees
  • PRGO N/A
  • FOLD N/A
  • Industry
  • PRGO Biotechnology: Pharmaceutical Preparations
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRGO Health Care
  • FOLD Health Care
  • Exchange
  • PRGO Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • PRGO 3.5B
  • FOLD 2.9B
  • IPO Year
  • PRGO 1991
  • FOLD 2007
  • Fundamental
  • Price
  • PRGO $26.77
  • FOLD $6.10
  • Analyst Decision
  • PRGO Buy
  • FOLD Buy
  • Analyst Count
  • PRGO 3
  • FOLD 10
  • Target Price
  • PRGO $33.00
  • FOLD $16.22
  • AVG Volume (30 Days)
  • PRGO 1.5M
  • FOLD 5.3M
  • Earning Date
  • PRGO 05-07-2025
  • FOLD 05-01-2025
  • Dividend Yield
  • PRGO 4.33%
  • FOLD N/A
  • EPS Growth
  • PRGO N/A
  • FOLD N/A
  • EPS
  • PRGO N/A
  • FOLD N/A
  • Revenue
  • PRGO $4,335,200,000.00
  • FOLD $543,141,000.00
  • Revenue This Year
  • PRGO $3.19
  • FOLD $19.85
  • Revenue Next Year
  • PRGO $2.26
  • FOLD $23.50
  • P/E Ratio
  • PRGO N/A
  • FOLD N/A
  • Revenue Growth
  • PRGO N/A
  • FOLD 28.25
  • 52 Week Low
  • PRGO $23.14
  • FOLD $5.81
  • 52 Week High
  • PRGO $30.93
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • PRGO 52.70
  • FOLD 39.70
  • Support Level
  • PRGO $26.19
  • FOLD $6.05
  • Resistance Level
  • PRGO $27.40
  • FOLD $6.37
  • Average True Range (ATR)
  • PRGO 0.57
  • FOLD 0.24
  • MACD
  • PRGO 0.03
  • FOLD 0.04
  • Stochastic Oscillator
  • PRGO 45.93
  • FOLD 33.51

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: